Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation.
about
Interaction of soluble CD163 with activated T lymphocytes involves its association with non-muscle myosin heavy chain type AElevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3Scavenger Receptors: Emerging Roles in Cancer Biology and ImmunologyEvolution of the CD163 family and its relationship to the bovine gamma delta T cell co-receptor WC1.Clinical significance of sCD163 and its possible role in asthma (Review).Soluble CD163 as a marker of macrophage activity in newly diagnosed patients with multiple sclerosis.High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis.Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals.Only the soluble form of the scavenger receptor CD163 acts inhibitory on phorbol ester-activated T-lymphocytes, whereas membrane-bound protein has no effect.CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response.Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infectionDiagnostic value of urine sCD163 levels for sepsis and relevant acute kidney injury: a prospective studyBANK1 and BLK act through phospholipase C gamma 2 in B-cell signalingSoluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy.The CD14 C-260T single nucleotide polymorphism (SNP) modulates monocyte/macrophage activation in treated HIV-infected individuals.Gene expression profiles of bronchoalveolar cells in pulmonary TBBiomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.Associations between Cognition, Gender and Monocyte Activation among HIV Infected Individuals in NigeriaSoluble membrane receptors, interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock.Human cytomegalovirus interleukin-10 polarizes monocytes toward a deactivated M2c phenotype to repress host immune responsesMyeloid cells in cancer progression: unique subtypes and their roles in tumor growth, vascularity, and host immune suppression.Urinary Soluble CD163 in Active Renal VasculitisLevels of soluble CD163 and severity of malaria in children in Ghana.Structural basis for inflammation-driven shedding of CD163 ectodomain and tumor necrosis factor-α in macrophages.Soluble ectodomain CD163 and extracellular vesicle-associated CD163 are two differently regulated forms of 'soluble CD163' in plasmaMonocyte-lymphocyte cross-communication via soluble CD163 directly links innate immune system activation and adaptive immune system suppression following ischemic stroke.The Search for a Biomarker of Relapse in ANCA-Associated Vasculitis.Soluble CD163: A novel biomarker for the susceptibility to sepsis in severe burn injuries.Tumor necrosis factor α-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163.Phenotypic correlations between monocytes and CD4+ T cells in allergic patients.CD163 identifies a unique population of ramified microglia in HIV encephalitis (HIVE).Machine-learning approach identifies a pattern of gene expression in peripheral blood that can accurately detect ischaemic stroke.Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis.
P2860
Q24306764-BDCD5DCA-3284-4994-9E9B-F1486BED4A7EQ24681059-7E551529-778A-4281-8595-93F07AF50446Q26799114-78850C4A-E55D-4E86-8FF5-9ACEC8C32807Q33605328-98493D8F-6B74-4D35-B45E-621A8CFBA9A2Q33674640-C2AED41D-5672-40CA-85D0-0EE0F93B19F8Q33700473-A07C89C2-6266-48F4-82D1-D99901EC5566Q33765551-F14DD1BB-59C9-44C3-AB48-3F117B28F4A7Q33916381-D1B8B324-A1A7-434A-8ADD-41787335638DQ34147333-CFC7003E-6FF5-4EA7-89E5-EBBA099DA0C4Q34358140-E679BA1F-537B-4656-B69B-2260C41CA049Q34396067-79597064-6B7A-4EEA-AC01-A4F05487D5A1Q34421874-75290D26-3BB1-41D1-8841-5FF9C0AD4BF3Q34652368-F5760115-CF34-4748-8C1B-BF6D225E6701Q35016650-2BC495F5-C4A0-4430-9CEB-CA6FEBE3DBDAQ35030351-BA3FE3A8-BC80-474E-8EF6-06CEF853BB95Q35150399-984EABDA-FF93-4FAC-881A-B3854252927AQ35364112-0201E150-FEB8-4662-AE41-6916A1B81D24Q35909822-6D40968A-0EDA-4EA7-A5C5-351919FD69DCQ36336058-54F4A461-0DC2-4EDA-86DE-BDB5439FFCF0Q37123220-5AD0F7B0-B3CB-4EC7-9ED8-7A42D0ABFB4CQ37866991-A754DDD7-F2CB-431B-B4E5-6CFF9C10CC1FQ39950079-D60CA37A-0673-40C8-A4FE-9D5926417191Q41833572-5CA37BAC-D2C6-4A59-8697-E8B9F3DD9411Q41863389-FAC6F6A9-E255-467B-9167-CB95C15E90B8Q42275739-FF6277D2-A54D-4BEC-9AC1-E6610E0E7A2DQ42374943-78D5598F-7808-4C56-A869-6E39D2098AE1Q42399755-CE697B42-065C-4A6A-B519-CB685574445CQ42750527-A765FF9B-24E6-40C6-838C-A986D6304BE8Q42921094-9ADFE9DE-E879-4EBD-9C6B-2997DE51FB26Q45830978-2474AC27-EBA6-4F14-AFD4-C6B38C259A94Q46381674-BFE60C1D-A7FB-4AD1-A89C-35C39F634AC1Q46950395-1FF6899E-A724-4E43-AAB3-E3D89276EB83Q47596781-11072C18-4611-40C4-B4B2-BB634BEDD084
P2860
Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation.
@ast
Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation.
@en
Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation.
@nl
type
label
Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation.
@ast
Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation.
@en
Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation.
@nl
prefLabel
Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation.
@ast
Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation.
@en
Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation.
@nl
P356
P1476
Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation.
@en
P304
P356
10.1006/BBRC.2001.5845
P407
P577
2001-11-01T00:00:00Z